Home » Newsletters » BioWorld Science

BioWorld Science

July 21, 2014

View Archived Issues

[123I]ABC-577 as a novel Abeta SPECT imaging agent

Inhibiting tau oligomer formation for the potential treatment of AD

Johnson & Johnson reviews progress of second quarter 2014

Navidea forms radiopharmaceuticals enterprise with Rheumco

Amgen reports first phase III trial results for AMG-416 in secondary hyperparathyroidism

Rigel advances fostamatinib into phase III for ITP

ViaCyte files IND for VC-01 encapsulated cell replacement therapy for type 1 diabetes

Bayer reports 2-year results from VIVID-DME study of aflibercept

ITCA-650 proves beneficial in patients with diabetes and severe hyperglycemia

Combined acetylcholinesterase inhibitor/calcium channel blocker tested in AD model

Novel transgenic model of early Alzheimer's disease induces amyloid cascade

Sanwa Kagaku Kenkyusho discloses new V2 receptor agonists

Novel agents for Alzheimer's disease disclosed by JST

Purdue Pharma divulges novel opioid receptor agonists

Durata Therapeutics launches Dalvance in U.S.

Cadila Healthcare patents novel HIF prolyl-hydroxylase inhibitors

Phase I study of Alkermes' MS candidate ALKS-8700 begins

Polish scientists prepare novel peptidomimetics

Basilea Pharmaceutica synthesizes novel PDE4 inhibitors

Rexahn advances phase I study of Supinoxin for solid tumors

Chugai gains rights to market palonosetron-based products in U.K. and Ireland

AbbVie and Shire reach agreement on business combination

MedPacto advances preparations for first phase I study of TEW-7197

Auspex Pharmaceuticals initiates pivotal trial of SD-809 in tardive dyskinesia

Basilea updates on European launch strategy for ceftobiprole medocaril

Bioniche plans BLA submission for bladder cancer therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....